Economics of AIDS
 |
Six countries and three regional programs are being invited as early applicants to participate in the full process of the new funding model, from submitting a concept note to creating a new grant. The countries – Zimbabwe, El Salvador, Myanmar, the Democratic Republic of the Congo, Kazakhstan and the Philippines – will be able to access a total of US$364 million in new funding in the transition period. They can also apply for additional funds that incentivize ambitious and high impact investments and co-financing.
|
 |
The Global Fund is changing its funding model. The new model will change the way the Global Fund assesses, approves, disburses, and monitors grants to increase successful applications, improve implementation, and ultimately achieve greater impact. The new model will increase engagement between applicants and the Global Fund and provide implementers with more flexibility, predictability, and clarity.
|
 |
A transition to the new funding model is underway. Access to funding in the transition phase is by invitation, and special consideration will be given to countries in a position to achieve rapid impact, those at risk of service interruptions, and those currently receiving less than they would under the new funding model’s allocation principles. There is diversity across regions and diseases and types of applicants, so that elements of the new funding model can be tested and refined. |
 |
Principles of the new funding model •Greater alignment with country schedules, context, and priorities •Focus on countries with the highest disease burden and lowest ability to pay, while keeping the portfolio global •Simplicity for both implementers and the Global Fund •Predictability of process and financing levels •Ability to elicit full expressions of demand and reward ambition |
 |
The new model provides implementers with more flexible timing, better alignment with national strategies and greater predictability on the level of funding available. There is more active engagement with implementers and partners throughout grant application and implementation to ensure greater global impact. |
 |
People who inject drugs should benefit from the large increases in the global resources available for HIV. However, it is difficult to measure how much of global HIV spending actually goes into harm reduction. Although harm reduction is relatively invisible in national and international budgets, it is possible to calculate a plausible estimate of HIVrelated harm reduction expenditure in low and middle income countries between 2007 and 2009. These results demonstrate the degree to which the international community is failing to address the issue of HIV among injecting drug using populations. |
 |
This report is based on analysis of data provided by the 23 donor government members of the Organisation for Economic Co-operation and Development (OECD)’s Development Assistance Committee (DAC) and the European Union (EU). It includes their combined bilateral assistance and contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) and to UNITAID. |
 |
The Philippines, while seemingly fortunate in thus far being able to avert a full-blown HIV/AIDS epidemic, remains at risk for this potentially disastrous possibility. On both the policy and program fronts, strategic areas have been identified to better focus the various sector-specific prevention and control activities. Nonetheless, if recent and current financing and allocation patterns are any measure, the reality may be far from the drawing board ideal. |
